<> /* Style Definitions */ span.
prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.
prnews_a
The medical-engineering interdisciplinary research team of Prof. Qiu Wei from the Department
Time of Update: 2022-04-27
Qiu Wei's medical-engineering interdisciplinary research team from the Department of Ultrasound Medicine, West China Hospital, Sichuan University published a paper entitled "A Library of ROS-Catalytic Metalloenzyme Mimics with Atomic Metal Centers" in Advanced Materials (IF: 30.
After entering the medical insurance catalog, a group of pharmaceutical companies said they would actively prepare production capacity
Time of Update: 2021-12-31
"Under the background that the price reduction of drugs in the medical insurance catalogue has become a general trend, how can we further ensure product quality while meeting demand?
Facing stricter supervision and fierce competition, medical insurance pharmacies are actively integrating into new business formats
Time of Update: 2021-12-07
In this context, data from leading retail pharmacies can be found that in the first half of this year alone, the six major chain medical insurance designated stores accounted for more than 80% of the total.
271 drugs compete for the new version of the medical insurance catalog: before 2016, the opportunities for listed drugs are still active
Time of Update: 2021-09-13
The 2020 national medical insurance drug catalog adjustment has given these provinces an opportunity to supplement the catalog products-"Condition 7: Before December 31, 2019, enter 5 or more drugs in the latest provincial basic medical insurance drug catalog .
Analysis of 271 drugs competing for the new version of the medical insurance catalogue
Time of Update: 2021-09-13
that generic drugs whose generic names have not been included in the medical insurance are basically difficult to enter the medical insurance list, unless their indications or functions and indications undergo major changes
State Food and Drug Administration: Olympus, Braun Medical and other four companies actively recalled medical devices
Time of Update: 2021-09-13
Braun Surgical SA voluntarily recalls Monosyn Synthetic absorbable surgical sutureBraun Medical Spain Joint Stock Company B.
Many companies actively recall related illegal medical device products
Time of Update: 2021-08-09
) has voluntarily recalled the steel and nickel-titanium mechanical root canal instrument Mani NRT Fur (registration number: National Machinery Injection 20152172611) .
Medical insurance e-vouchers activate more than 720 million users across all channels
Time of Update: 2021-07-30
The medical insurance electronic voucher is issued by the unified national medical insurance information platform, which is the identity of the insured people and related
Bicar® Pharma is registered and activated in the Drug Evaluation Center of the National Medical Products Administration as an API
Time of Update: 2021-07-28
Bicar® Pharma is registered and activated in the Drug Evaluation Center of the National Medical Products Administration as an API
[A series of activities of the Lymphocytic Disease Group of the Hematology Branch of the Chinese Medical Association]
Time of Update: 2021-06-22
Diagnosis and treatment of EBV-T/NK-LPD Professor Wang then focused on the EBV-related T/NK cell lymphoid tissue proliferative disease (EBV-T/NK-LPD), which is a type of fatal disease that has attracted much attention in clinical practice.
of activities of the Lymphocytic Disease Group of the Hematology Branch of the Chinese Medical Association]
Time of Update: 2021-06-18
Summary Professor Qian Wenbin concluded: CAR-T therapy has achieved good results in B-cell lymphoma, but currently about 50% of patients still cannot benefit from CAR-T therapy, and about 20% of patients Disease progression after obtaining CR .
Wonderful review｜A series of activities of the Lymphocytic Disease Group of the Hematology Branch
Time of Update: 2021-06-05
Conference speech The first session of the academic lecture: Progress in the molecular pathology of highly aggressive B-cell lymphoma was presided over by Professor Zhou Xiaoge from Beijing Friendship Hospital and Professor Wang Yinping from Jilin University First Hospital.
activities of the newly revised "Regulations on the Supervision and Administration of Medical Devices"
Time of Update: 2021-06-04
Department and Director Zhao Yan of the Evaluation Center personally came to the site to teach. Organize training courses for key medical equipment legal professionals across
"Nature-Medical": "Subtraction" of CAR-T cells can have anti-tumor activity
Time of Update: 2021-05-08
cells carrying the 4-1BB costimulatory domain, this pre-activation actually improves the cell's killing ability and anti-tumor activity against B cells. Co-corresponding author Professor Marco Ruella pointed out
Shanghai CA actively responds to the guidance of the National Medical Insurance Administration
Time of Update: 2021-04-22
In order to fully implement the spirit of General Secretary Jin Ping’s important instructions on the network
GEM surges Medical devices and sub-new shares are active again
Time of Update: 2021-02-08
the introduction of medical reform-related opinions coupled with market risk aversion, medical devices and pharmaceutical manufacturing sector-related stocks continued to receive financial attention, Le Heart Medical and Jiuan Medical rose and stopped for 4 consecutive trading days.
Liaoning, Henan and other five provinces actively respond to the classification and classification of medical device enterprises supervision and management
Time of Update: 2021-02-02
. is to standardize the quality system of enterprises. Clarify the requirements for medical device manufacturers to submit self-examination reports on the operation of the annual quality management system. is to focus on risk regulation
Participate in Metz Medical Hypertension Emergency and Anticoagulant-related research and adjustment activities, win a good gift!
Time of Update: 2020-06-22
with economic growth and the continuous improvement of living standards, the incidence of cardiovascular diseasein in China shows a "one high one low" trend: high incidence, low age of patients (younger). How to effectively
